Guru Ownership Trend
Guru Analysis for Centessa Pharmaceuticals plc (CNTA)
Centessa Pharmaceuticals plc (CNTA), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q4 2025, a total of 4 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $68.11 M.
Top institutional holders include Lee Ainslie and Chuck Royce.
Institutional sentiment is currently Bullish. This is evidenced by a $22.46 M net inflow during the quarter.
Recent activity highlights Paul Tudor Jones who increased their stake by 110.7%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q4 2025)
Guru Consensus (Q4 2025)
FAQs for Centessa Pharmaceuticals plc (CNTA)
Major holders include Lee Ainslie ($41.11 M), Chuck Royce ($9.08 M), Renaissance Technologies ($6.99 M). According to the latest reported data, 4 tracked investment managers collectively hold approximately 2.41 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $22.46 M, with 4 managers increasing positions and 1 managers reducing holdings.
During the most recent reporting period, 0 managers trimmed their positions, while 1 fully exited CNTA. The total reported sell value was $26.01 M.
Yes, 1 managers opened new positions in CNTA, and 3 increased their existing holdings. The total reported buy value was $48.47 M.